FP13.02 Pembrolizumab + Pemetrexed-Platinum vs Pemetrexed-Platinum for Metastatic NSCLC: 4-Year Follow-up From KEYNOTE-189

Jhanelle E. Gray, Delvys Rodríguez‐Abreu, Steven Powell, Maximilian J. Hochmair, Shirish M. Gadgeel, Emilio Esteban, Enriqueta Felip, G. Speranza, F. De Angelis, Manuel Dómine, Susanna Y. Cheng, H. Bischoff, Nir Peled, Martin Reck, Rina Hui, Edward B. Garon, Michael Boyer, Takayasu Kurata, Jing Yang, E. Jensen, Francis Ribeiro de Souza, Marina Chiara Garassino